Location: East Of England
Speciality: Cath Lab and ICD Physiologist
Location: South Central
Speciality: BSE Echocardiographer
Location: North West England
A new drug has been proven to be adequate at treating stroke in irregular heartbeat patients, while also being easier to administer.
Research published in the New England Journal of Medicine found that rivaroxaban was just as effective as warfarin at cutting the risk of stroke among patients with this condition.
Usage of warfarin has to be monitored as its effects can be altered by other medications and diet, while those taking rivaroxaban do not require such close observation.
Manesh R Patel, of Duke University, said: "The results of this large global trial have convincingly shown rivaroxaban to be an alternative to warfarin in treating patients with atrial fibrillation and, importantly, with no increase in bleeding."
In other news, research published in the Journal of General Internal Medicine has found that heart patients who obtained new statin prescriptions through a mail-order system experienced better control of their cholesterol than those who collected their drugs from a pharmacy.
Written by Angela Newbury
The winter brings with it much cooler temperatures, which can have an impact of many elements of health. This...
Diet is often linked to heart health, with people making recommendations about alcohol, sugar or fat intake....
A new study has linked home cooking to heart disease, suggesting that the more time people spend preparing...
Cardiology is an exciting field of medical science to be involved in, with the advancement of technology having...